Using wide-field images and deep learning, researchers developed an analysis system of suspicious pigmented skin lesions for more effective and efficient skin cancer detection.
Image courtesy of the reseearchers
Using deep convolutional neural networks, researchers devise a system that quickly analyzes wide-field images of patients’ skin in order to more efficiently detect cancer.
Melanoma is a type of malignant tumor responsible for more than 70 percent of all skin cancer-related deaths worldwide. For years, physicians have relied on visual inspection to identify suspicious pigmented lesions (SPLs), which can be an indication of skin cancer. Such early-stage identification of SPLs in primary care settings can improve melanoma prognosis and significantly reduce treatment cost.
The challenge is that quickly finding and prioritizing SPLs is difficult, due to the high volume of pigmented lesions that often need to be evaluated for potential biopsies. Now, researchers from MIT and elsewhere have devised a new artificial intelligence pipeline, using deep convolutional neural networks (DCNNs) and applying them to analyzing SPLs through the use of wide-field photography common in most smartphones and personal cameras.
DCNNs are neural networks that can be used to classify (or “name”) images to then cluster them (such as when performing a photo search). These machine learning algorithms belong to the subset of deep learning.
Using cameras to take wide-field photographs of large areas of patients’ bodies, the program uses DCNNs to quickly and effectively identify and screen for early-stage melanoma, according to Luis R. Soenksen, a postdoc and a medical device expert currently acting as MIT’s first Venture Builder in Artificial Intelligence and Healthcare. Soenksen conducted the research with MIT researchers, including MIT Institute for Medical Engineering and Science (IMES) faculty members Martha J. Gray, W. Kieckhefer Professor of Health Sciences and Technology, professor of electrical engineering and computer science; and James J. Collins, Termeer Professor of Medical Engineering and Science and Biological Engineering.
Soenksen, who is the first author of the recent paper, “Using Deep Learning for Dermatologist-level Detection of Suspicious Pigmented Skin Lesions from Wide-field Images,” published in Science Translational Medicine, explains that “Early detection of SPLs can save lives; however, the current capacity of medical systems to provide comprehensive skin screenings at scale are still lacking.”
The paper describes the development of an SPL analysis system using DCNNs to more quickly and efficiently identify skin lesions that require more investigation, screenings that can be done during routine primary care visits, or even by the patients themselves. The system utilized DCNNs to optimize the identification and classification of SPLs in wide-field images.
Using AI, the researchers trained the system using 20,388 wide-field images from 133 patients at the Hospital Gregorio Marañón in Madrid, as well as publicly available images. The images were taken with a variety of ordinary cameras that are readily available to consumers. Dermatologists working with the researchers visually classified the lesions in the images for comparison. They found that the system achieved more than 90.3 percent sensitivity in distinguishing SPLs from nonsuspicious lesions, skin, and complex backgrounds, by avoiding the need for cumbersome and time-consuming individual lesion imaging. Additionally, the paper presents a new method to extract intra-patient lesion saliency (ugly duckling criteria, or the comparison of the lesions on the skin of one individual that stand out from the rest) on the basis of DCNN features from detected lesions.
“Our research suggests that systems leveraging computer vision and deep neural networks, quantifying such common signs, can achieve comparable accuracy to expert dermatologists,” Soenksen explains. “We hope our research revitalizes the desire to deliver more efficient dermatological screenings in primary care settings to drive adequate referrals.”
Doing so would allow for more rapid and accurate assessments of SPLS and could lead to earlier treatment of melanoma, according to the researchers.
Original Article: An artificial intelligence tool that can help detect melanoma
More from: Massachusetts Institute of Technology
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Cooper offers a world-first test of newly approved melanoma therapy to be made in Philly
A South Jersey woman was the first in the world to receive the therapy as her first treatment for advanced melanoma. The therapy eventually will be made in Philadelphia's Navy Yard.
- Cutting-edge cancer therapy helps treat melanoma, doctor's insights
A new cancer therapy to treat advanced melanoma, the deadliest form of skin cancer, was recently approved by the food and drug administration.
- 27 institutions cleared to offer new advanced melanoma therapy
The FDA recently approved the first tumor-infiltrating lymphocyte, or TIL, therapy to treat advanced melanoma, and 27 institutions have so far been authorized to deliver the treatment. Federal ...
- Immunocore and BMS partner to investigate first-line treatment for melanoma
Immunocore has signed a clinical trial collaboration and supply agreement with Bristol Myers Squibb (BMS) to develop its drug IMC-F106C as a combination treatment for cutaneous melanoma. IMC-F106C, a ...
- Updates on IHC Stains in Mohs Micrographic Surgery for Melanoma
The following is a summary of “An Update and Review of Clinical Outcomes Using Immunohistochemical Stains in Mohs Micrographic Surgery for Melanoma,” published in the January 2024 issue of Dermatology ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”melanoma” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
- Boca Raton hospital says artificial intelligence can detect breast cancer earlier
Artificial intelligence, or AI, is a transformative tool in the healthcare industry. It’s being used for things like transcribing documents, improving doctor-patient communication, and helping create ...
- Pill camera tested for use in detecting cancer
Prof James Turvill said if the trials proved successful the camera pill could be in general use by 2027. York and Scarborough Teaching Hospitals NHS Foundation Trust has been awar ...
- Ask the doctors: Can AI detect pancreatic cancer earlier?
Q: A dear friend was diagnosed with pancreatic cancer. It was so advanced, he died just a month later. I recently saw a discussion on television about using AI to detect pancreatic cancer early, while ...
- Virginia Tech researchers develop rapid test to detect cancer in dogs
(WDBJ) - Cancer is common in dogs, with some breeds being more prone ... Researchers at Virginia Tech have developed a new rapid test that allows for potential early detection.
- Doctors: Early screenings and detection are key to protecting yourself against cancer
Early screenings and detections are helping people get their cancer diagnosis early. Dr. Asti says over the last decade, cancer diagnoses have been up but mortality is down. With cancers being caught ...
Go deeper with Google Headlines on:
[google_news title=”” keyword=”detecting melanoma” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]